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Abstract
Purpose—To examine the effect of correcting coronary heart disease (CHD) risk factors for
long-term within-person variation on CHD risk.
Method—Using 5533 men and 7301 women from the Atherosclerosis Risk in Communities
(ARIC) Study, we compared models incorporating risk factors measured at a single visit and
models incorporating additional measurements for systolic blood pressure, total cholesterol and
high-density lipoprotein cholesterol taken 3 years prior to baseline.
Results—The largest change away from null was seen for systolic blood pressure: Hazard ratio
(HR) 1.38 to 1.69 (+81%) in women and HR 1.26 to 1.41 (+56%) in men. Hazard ratios also
decreased for age (−32% in women, −9% in men), race (−67% in women), diabetes (−13% in
men and women), and medication use for hypertension (−27% in women, −26% in men) and
cholesterol (−97% in women, HR 1.06 to 0.93 in men). The area under the ROC curve did not
improve significantly in men or women, while reclassification was only significant in women
(NRI 5.4%, p = 0.016).
Conclusion—Modeling long-term variation in CHD risk factors had a substantial impact on HR
estimates, with new effect estimates further from the null for some risk factors and closer for
others including age and medication use, but only improved risk classification in women.
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Models of coronary heart disease (CHD) risk drive both public health policy decisions and
individual treatment recommendations. However, CHD risk prediction usually relies on
measurement of risk factors at a single point in time. Some risk factors are well described
with one baseline measure, but others exhibit long term variation - a combination of
instrument measurement error, physiologic short-term variability, and long term changes.
Prediction and relative risks are usually estimated over years of follow-up, during which risk
factor levels vary. These variations can affect the observed relationship of all risk factors to
CHD, those with and without variation, and can affect both individual level prediction and
population level estimates of relative risk (as well as odds ratios and relative hazards).
Strachan and Rose noted that variation leads to underestimation of the potential benefits of
both a population shift, for example to lower blood pressure, and a high risk reduction
strategy, partially through an underestimation of the population attributable risk.(1) Incorrect
assumptions about the effectiveness of screening can also result from the effect of variation
on identification of high risk people.
Previous methods for accounting for the effect of variation in risk factors adjust the relative
risk estimates directly and do not allow for adjustment to the absolute individual risk.(2–4)
Consequently, these methods also do not allow empirical assessment of the potential
improvement in prediction of disease risk obtained by accounting for variation, and the
effect of accounting for variation on prediction is unknown. To address the question of
whether accounting for risk factor variation has utility in prediction of disease risk, our study
outlines a framework which allows for adjustment for correlations between risk factors in a
measurement error model, in which measurements at different times are considered repeated
measures of the long term average. This method is then applied to a United States
community based sample of middle-aged black and white men and women who were
measured at baseline and three years prior. We used regression calibration to obtain direct
estimates of the long term average systolic blood pressure, total cholesterol and HDL
cholesterol and examined the effect of using those values rather than a single measurement
on relative hazards for CHD for both the measures with variation and those only measured at
baseline, including race. We also assessed the effect of correction for long-term variation on
prediction. This investigation provides one of the largest systematic implementations of the




The Atherosclerosis Risk in Communities (ARIC) Study is an ongoing prospective study
that examines clinical and subclinical atherosclerotic diseases in a cohort of 15,792 persons,
aged 45–64 years at baseline examination, selected from four U.S. communities. The
sampling procedure and methods used in ARIC have been described in detail elsewhere.(5)
The initial visit was followed by a visit three years later. For this study, the second visit was
considered the baseline for single measurements of risk factors and for follow-up and
information from the first visit (three years prior) was only used to estimate long-term
variation. We excluded participants who reported ethnicity other than African-American or
Caucasian (n=48), who reported prevalent CHD at the first visit or incident CHD prior to the
second visit (n=1209), or had missing information on the risk factors at either visit
(n=1701). After these exclusions, there were 12,834 participants for the present analysis
(7301 women and 5533 men).
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Information on age, gender, and race were obtained from home and clinic interviews
conducted at the first visit. Smoking status was obtained from interview at each visit, as was
current medication use.(6) Blood was collected at each visit, and total and HDL cholesterol
testing was centralized.(7) Diabetes was defined at each visit as the presence of any one of
the following: fasting glucose ≥ 126 mg/dL, non-fasting glucose ≥ 200 mg/dL, current use
of diabetic medication, or reported physician diagnosis. Blood pressure was measured three
times at each visit and the average of the second and third measurement was used in the
analysis.(8)
Outcome assessment
CHD incidence was obtained through annual surveillance of patients, hospital records and
death certificates through 2001. The abstraction and adjudication of these records has been
previously described.(6, 9, 10) An event was defined as a definite or probable hospitalized
myocardial infarction or a definite CHD death. Follow-up time was considered to start at the
baseline (second) visit for all analyses.
Statistical analysis
Long-term variation was adjusted for in three continuous risk factors: HDL cholesterol, total
cholesterol, and systolic blood pressure. Our method of adjustment is based on the
estimation of a long-term average value, and dichotomous measures, such as current
smoking status or diabetes diagnosis, do not fit as well into this framework. While a long
term average could be estimated if desired, for this study only the baseline values of
smoking status, diabetes diagnosis, and medication use were used. Age and race were also
assumed to be well-characterized by a single measurement and the baseline values were
included in all models. All models were stratified by gender.
We performed a series of analyses to explore the effect of different adjustment strategies.
This first analysis was a Cox proportional hazards model in which baseline values alone
were used for all risk factors with no adjustment for long-term variation. The second
analysis used the mean of the baseline values and the visit three years prior for the
continuous variables in a Cox proportional hazards model, adjusting for some variation but
not using the covariance between risk factors. The third analysis, regression calibration as
outlined by Carroll, Ruppert and Stefanski (11), used all the available relationships between
all of the risk factors to generate an adjusted estimate for each continuous risk factor.
Conceptually, this process estimates the actual desired variable, eg long term average blood
pressure, using a weighted average of the best guess for an individual (the individual mean)
and the mean for similar people (people with similar levels of the other risk factors), with
the weight for the best guess for the individual being a function of the reliability of the
measurement. The adjusted estimate was then used in a Cox proportional hazards model to
obtain the prediction and relative hazard estimates. Substantial methodological and applied
research has been dedicated in recent years to survival analysis with covariates subject to
measurement error. (12–14) These analyses were implemented using R version 2.6.
We also conducted analyses using two available software packages: the method outlined by
Rosner and colleagues (4) and available from Spiegleman and colleagues (15) in the relibpls
macro in SAS and the rcal procedure in Stata, developed by Hardin et al (16). The relibpls
procedure uses the variability in the repeated measures to directly adjust the effect estimates.
The rcal procedure uses the same regression calibration structure as the proposed method,
but does not directly generate the individual values for the variables with variation. The rcal
procedure currently cannot run Cox proportional hazards models, so a Poisson model was
used instead. For the mean and regression calibration models, percent change in excess
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relative hazard (RH) from the baseline model was also calculated as 100%*[(RHcorrected-1) -
(RHbaseline-1)]/(RHbaseline-1) to show whether the change in the model strengthened or
weakened the effect.
To compare predictive ability, we examined the AUC for the first three models. We were
unable to calculate the AUC for the final two models because the corrected estimates of
relative risk do not have corresponding corrected risk factor values. The AUC was generated
using the Kaplan-Meier-like method of Chambless and Diao.(17) We also generated 10-year
predicted CHD event risk for each participant using the baseline hazard function from each
model and the individual covariates. Participants were grouped into deciles of 10-year risk
for each model and observed event rates in each decile were calculated to assess calibration
using the Hosmer-Lemeshow test. (18)
Risk reclassification (19, 20) was assessed by categorizing the predicted 10-year risk for
each model into categories of less than 5%, 5% to less than 10%, 10% to less than 20%, and
20% or higher. We then compared the assigned categories for a pair of models and
calculated the Net Reclassification Improvement (NRI), (21) which compares the shifts in
reclassified categories by observed outcome, and the Integrated Discrimination
Improvement (IDI), (21) which directly compares the average difference in predicted risk.
Results
Baseline characteristics
Table 1 summarizes the distribution of the key risk factors for the baseline visit and the
distribution of the previous visit values. There was fluctuation in smoking status and
diabetes categorization. There were current smokers at baseline who did not report smoking
at the previous visit (2% men, 1% women) and people who did not report smoking at
baseline but were current smokers at the previous visit (4% men and women). There were
also new cases of diabetes at the baseline visit compared to three years earlier (6% men, 5%
women) and people who were not considered diabetic at baseline but were at the previous
visit (1% men and women). Table 1 also shows the correlation between the baseline and
previous visit for systolic blood pressure, total and HDL cholesterol which are the focus of
correction for long term variation.
Correlations over time
Table 2 displays the correlations between the mean values of the time-varying risk factors
and the baseline values of the factors modeled without variation for men and women.
Pearson correlations are shown when both factors are continuous and point biserial
correlations are shown when one is dichotomous. These relationships are used in the
regression calibration and explain some of the changes in the relative hazard estimation. Of
note, age is correlated with blood pressure and HDL cholesterol in men and only blood
pressure in women, while African-American race is correlated with higher blood pressure in
men and women and additionally with higher total cholesterol in women. The mean values
of blood pressure are also more correlated with the mean values of HDL and total
cholesterol in women than in men.
Relative hazard estimates
Tables 3 and 4 show the results of the multivariate analyses in men and women,
respectively. Figure 1 further highlights the change in relative hazard between the baseline
and regression calibration models. As shown, the effect of adjustment is strongest using the
regression calibrated approach, but using the mean of the two visits changes relative hazards
in the same direction. While the specific estimates of the models vary slightly, the
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relationship of the Rosner and rcal results to the estimates of effect in the baseline model is
consistent. Comparing the baseline model to the regression calibrated model, we observe an
increase in the relative hazard of total cholesterol of 51% in men and 74% in women and an
increase in the relative hazard of systolic blood pressure of 56% in men and 81% in women.
The relative hazard for HDL changed from 0.62 to 0.53 in men, a 26% increase in effect,
and from 0.77 to 0.68 in women, a 43% increase in effect. We also observed decreases in the
effect of the factors modeled without variation in the regression calibration model with the
exception of smoking. The relative hazard for age decreased 9% in men and 32% in women,
the relative hazard for race decreased 67% in women and increased 5% in men, and the
relative hazard for diabetes decreased 13% in men and women. The relative hazard for
hypertension medication use decreased 26% in men and 27% in women, while the relative
hazard for cholesterol medication use decreased 97% in women and went from 1.06 to 0.93
in men. The relative hazard estimates for smoking remained relatively unchanged,
increasing slightly in men (1%) and women (7%).
Prediction
As shown in Table 5, the AUC increased from 0.701 for the baseline model to 0.704 for the
mean model in men and from 0.780 to 0.785 in women. However, no further increase was
seen for the regression calibration model, suggesting that the slight increase was due to the
additional information from the previous visit rather than the specific model. Bootstrapped
95% confidence intervals for the difference between the baseline and regression calibrated
models were (−0.020, 0.034) for men and (−0.029, 0.041) for women, showing no
significant improvement in the AUC using the regression calibrated model. All models were
calibrated and no improvement in reclassification measures was seen using multiple
measurements in the men. In the women, however, reclassification was improved by using a
combined measurement over the baseline value (NRI 6.4%, p = 0.008)
Discussion
This study examined the effect of correction for long-term variation in multiple risk factors
on CHD risk estimation and prediction. Correcting for long term variation has a substantial
effect onthe relative hazard estimates, strengthening the relative hazards for systolic blood
pressure, total and HDL cholesterol, with little change for smoking, and weakening of the
relative hazards of age, medication use, and, in women, race. The regression calibration
method generated an estimate of the value of the risk factors corrected for long-term
variation, which allowed us to also examine the effect of correction on prediction. There was
no significant increase in the AUC in the mean model compared to the baseline model, and
no further improvement in the regression calibration model. However, both the mean and the
regression calibration models improved risk classification in women compared to the
baseline model.
Some of the changes in hazard ratios due to adjustment for long term variation are suggested
by underlying risk factor relationships. For example, cholesterol and hypertension
medication use at baseline are likely to be related to cholesterol and blood pressure values 3-
years prior. Likewise the decrease in the hazard ratios for age in women might be related to
the stronger relationship between age and blood pressure in women than men. The lack of
change in the hazard ratio of smoking could be due to a lack of relationship between
smoking status and blood pressure and cholesterol levels.
This work builds on previously published findings on CHD risk from the ARIC cohort (22).
The increases seen in our estimates of relative effect are slightly higher than those shown by
single risk factor adjustment. MacMahon et al (23) found a 60% increase in the relative risk
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for blood pressure, while Law et al (24) and Verschuren et al (25) found increases in the
relative risk for of total cholesterol of around 40%.
The results of multivariable adjustment, on the other hand, will depend on which risk factors
are included in the model, though our results show similar direction to those seen in other
studies. Rosner et al (4) found an increase in the effects of cholesterol, glucose and blood
pressure, when variation in those variables was included, and a decrease in the effect of
smoking and BMI and age. Iribarren et al (26) showed increases in the hazard ratios of
serum cholesterol, blood pressure, and dietary cholesterol, when variation was included, and
mixed effects in smoking, and decreases in the hazard ratios of alcohol consumption and
abstinence and body mass index.
Emberson et al (27) used a model in which diastolic blood pressure and serum total
cholesterol were assumed to vary, while age, history of CHD, and smoking status were not
and found increases in all hazard ratios. To aid in the comparison, we provided the relative
hazards using the same variables but generated using the Rosner macro, which were very
similar to those obtained using our regression calibration method. This suggests that
differences in the results are not driven by the choice of method.
Previous studies have not examined the effect of correction for long term variation on
prediction. Our results show no significant improvement in discrimination resulting from the
additional information provided by the previous visit. This lack of improvement did not vary
across different methods of accounting for long term variation. The improvement in
classification seen in women but not in men may be due to the stronger correlations between
the two measurements in women, making the long term average a better estimate of the
effect in women. This finding would need to be replicated in additional populations.
Additionally, the utility of our method in adding predictive ability for other diseases, or if
expanded by using more than two measurements to include an estimate of trajectory rather
than averages, remains untested. It is clear, however, that using a corrected model does not
decrease predictive ability of the model. One potential advantage of correction for variation
on prediction worthy of further study is that it allows for the risk model not to depend on the
variability in a given population. Correction for variation may allow for more similarity in
models and calibration across populations.
This study is limited by having only two visits, three years apart, for each variable, and did
not include continuous measures of smoking and glycemic control. With more frequent
measurements, which may become increasingly available through electronic medical
records, the method could be extended to examine trajectories of change rather than a single
long-term value. Including continuous measures of glucose control and smoking would have
allowed improved understanding of the relationships between risk factors. Additionally, we
were also unable to separate the observed long-term variation into measurement
imprecision, short-term variability and long-term changes. However, decomposition would
not impact the final results of the present analysis. Also, our correction method is a first-
order correction and does not take into account the variance of the underlying estimate of the
long-term mean. We did check for a period effect and for a relationship between the
variability and age at baseline and found none. Variation in the mean time between visits
(mean 2.9 years, SD 0.2) in men and women led to some variability between the ages at the
two visits (correlation of 0.998 in men and 0.997 in women).. We were also limited by the
missing values in the data. We chose to use a listwise deletion approach rather than use the
other variables to both estimate the missing data and to derive the correlation structure for
the regression calibration. However, our approach does introduce potential biases in the
results if the missing values are not randomly distributed.
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The study does have substantial strengths. The time period of measurements and follow-up
is well suited to answer the question of previous variation on future risk prediction versus
relative hazard estimation. We also were able to correct for variation in multiple risk factors
simultaneously as well as see the effects of correction on the remaining risk factors. Finally,
our method provided an actual estimate of the underlying risk factor value and allowed us to
examine prediction.
Conclusion
We found the relative risks of CHD associated with higher blood pressure, total and HDL
cholesterol are substantially closer to the null while the relative risks for age, race (in
women), and diabetes are further from the null when models ignore long term variation. In
contrast, we found that adding one visit prior to baseline only improved CHD risk
classification in women. In addition, the methods we present allow estimation of the
underlying risk factor values and assessment of any change in prediction. Our results
suggest that correction for long-term variation using this method of regression calibration is
important in understanding the relative and predictive effects of CHD risk factors.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Abbreviations
ARIC Atherosclerosis Risk in Communities (study name)
AUC area under the receiver operator characteristic curve
BMI body mass index
CHD coronary heart disease
HDL high-density lipoprotein
HR hazard ratio
IRI Integrated Discrimination Improvement
NRI Net Reclassification Improvement
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Percent change in hazard ratios from the baseline model to the regression calibration model
for men and women. Percent change = (hazard ratio in regression calibration model-hazard
ratio in baseline model)/(hazard ratio in baseline model -1)*100.
*Percent change is not calculated for men because the estimates change effect direction.
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Age 57 (6) 54 (6)
African-American 20% -
Diabetic 14% 10%
Current Smoker 24% 25%
Cholesterol Medication 5% 3%
Hypertension Medication 27% 22%
HDL Cholesterol (mg/dL) 45 (13) 43 (14) 0.782
Total Cholesterol (mg/dL) 210 (39) 204 (37) 0.687
Systolic Blood Pressure (mm Hg) 122 (18) 122 (17) 0.673
WOMEN
Age 57 (6) 54 (6)
African-American 26% -
Diabetic 14% 10%
Current Smoker 21% 23%
Cholesterol Medication 6% 3%
Hypertension Medication 33% 31%
HDL Cholesterol (mg/dL) 58 (17) 56 (17) 0.805
Total Cholesterol (mg/dL) 218 (43) 214 (40) 0.678
Systolic Blood Pressure (mm Hg) 120 (19) 119 (19) 0.701
*
% or mean (SD)
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Table 5




AUC 0.701 0.704 0.704
Hosmer-Lemeshow Chi-squared (p-value) 12.4 (0.14) 12.3 (0.14) 13.5 (0.10)
NRI (p-value) - −1.1% (0.70) −0.2% (0.55)
IDI (p value) - 0.0 (0.47) 0.0 (0.60)
Percent reclassified - 14.5% 14.1%
Women
AUC 0.780 0.785 0.785
Hosmer-Lemeshow Chi-squared (p-value) 2.1 (0.98) 5.7 (0.68) 13.6 (0.09)
NRI (p-value) - 6.4% (0.008) 5.4% (0.016)
IDI (p value) - 0.011 (<0.001) 0.009 (<0.001)
Percent reclassified - 7.1% 9.8%
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